mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
-0.35 |
0.03 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.03 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.03 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.03 |